AUDICOR CE

Products	AUDICOR CE
Company	Inovise Medical, Inc.
Item	AUDICOR CE
Features	Solves a challenging problem identifying subtle heart failure in patients presenting with shortness of breath and complicating symptoms. Helps improve diagnostic confidence by adding an additional marker to your limited field tools. Provides diagnostic information leading to earlier and more appropriate treatment decisions. Detects the S3 heart sound, which in the presence of symptoms consistent with heart failure, is a highly specific marker of left ventricular dysfunction. Helps improve detection of subtle MIs that may otherwise be missed, especially UA/ NSTEMIs. Outperforms leading ECG devices 2:1 in overall detection in AMI.
Description	Inovise Medicals AUDICOR is the first, easy-to-use, non-invasive diagnostic technology helping medical professionals worldwide quickly rule-in cardiac dysfunction including acute heart failure, acute coronary syndrome, and other high-risk cardiac conditions. Designed to seamlessly fit into the existing workflow, AUDICOR products enable clinicians caring for cardiac patients in hospitals, clinics, as well as paramedics in the pre-hospital community, to rapidly and accurately assess high-risk cardiac patients. AUDICOR diagnostic data helps contribute in the earlier administration of definitive therapy, shorter lengths-of-stay, reduced hospitalizations, and reduce mortality.
Info	Inovise Medical, Inc. Customer Service: (503) 431-3800 Web site: http://www.inovise.com/

Related medicine products :

1. AUDICOR® 200D

TAG: AUDICOR

...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...

Medicine Products:

Human Immunodeficiency Virus 2 Antibody Confirmation by IFA Human Immunodeficiency Virus 1,2 Combined Antibodies with Reflex to HIV-1 Confirmation by Western Blot Human Immunodeficiency Virus 1 RNA Quantitative PCR with Reflex to Ultrasensitive RNA Quantitative PCR Human Immunodeficiency Virus 1 Antibody, Confirmation

(Date:11/29/2009)... The Academy of General Dentistry (AGD) ...CA, received the Mastership Award during the AGD,s...ers, commitment to excellence in dental education....ours of approved continuing dental education in th... dedicated to hands-on skills and techniques. , ...

(Date:11/29/2009)...one get blamed for something leads to more self-de... SUNDAY, Nov. 29 (HealthDay News) -- The blame gam...hen the target is innocent. , Researchers found...or a problem, even if it,s an unfair accusation, t...s, too. , "When we see others protecting their...

(Date:11/29/2009)... Traditional healthcare,s uncertain futu...dable alternative care. Affordable Acupuncture Sco... (PRWEB) November 29, 2009 -- Affordable Acupunc...r (2009) and has been met with enthusiasm and grat... can be attributed to two things, need and cost. ...

(Date:11/28/2009)...e variation believed to affect circadian rhythm,... -- New research suggests that an internal body cl...e development of bipolar disorder in children. ,... genetic makeup of 152 children with bipolar disor...od swings, and 140 children without the disorder. ...

(Date:11/27/2009)... Biotech firm Replikins Ltd. today issue...s genomic data. It shows that the lethality of th...) during the virus,s current outbreak in the sprin... of 2.0 (s.d. 0.1). The H1N1 infectivity count, ho... Boston (PRWEB) November 27, 2009 -- Biotech fir...

Breaking Medicine News(10 mins):Health News:Orange County Dentist Honored by The Academy of General Dentistry 2 Health News:When Accusations Start to Fly, They Multiply 2 Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2 Health News:Bipolar Disorder May Be Tied to Body Clock 2 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5

[1] Orange County Dentist Honored by The Academy of General Dentistry [1] When Accusations Start to Fly, They Multiply [0] Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities [0] Bipolar Disorder May Be Tied to Body Clock [0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased

...venue and Earnings Guidance for 2008, - Total Reve...268.0mm for Fourth Qua...p 16% to $1.59 for Full Year, (GAAP EPS down 11% t...thening Across Segments, - Reconfirming 2008 Reven...

..., Calif., Feb. 28 Cardiva Medical, Inc., a,privat...he Boomerang,Catalyst(TM) System announces that it...lyst II System on February 29 at 9:20am at the Med...n in Las Vegas, NV., The Boomerang Catalyst II Sy...

...he most effective treatment for lowering cholester...be safe in large clinical trials. Although side ef...especially musculoskeletal complications, have bee... of Arthritis Care & Research ( http://www.intersc...

...r 2007 And Full Year 2007 Highlights, - Revenue ... from the, fourth quarter of 2006. Revenue for the...rease from $1.3 billion for full year 2006., - Ave...lity Operating Income for the fourth quarter grew ...

...breast cancers for three receptors could help doct...rain metastases. A study published in the open acc...ents with tumours that are negative for estrogen r...brain metastases. Survival is also correlated to t...

...eb. 27 Today, the U.S. House,Foreign Affairs Comm...PEPFAR, the U.S. Global Leadership Against HIV/AID...08., Tony Perkins, President of Family Research C...ontained in earlier drafts. Previous,drafts would ...

inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the 'Investment in Innovation (In3) West' Conference on February 29, 2008 in Las Vegas, NV Tendon complications, though rare, linked to statins Brookdale Announces Fourth Quarter and Full Year 2007 Results Breast cancer subtypes linked to survival from secondary brain tumors Bipartisanship Trumps Liberal Agenda in PEPFAR Reauthorization

(Date:11/25/2009)...ire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ...ed to discovering, developing and commercializing ...nancial results for the fiscal year ended Septembe...$58.4 million in cash, cash equivalents and short ... Highlights ,, RG7128 ,, Phase 2b Trial...

(Date:11/25/2009)...ire/ -- The FDA granted traditional approval for I...ide reverse transcriptase inhibitor (NNRTI). INTEL...use in treatment-experienced adults who are experi...ant to an NNRTI and other antiretroviral (ARV) age... data from two Phase 3 studies known as DUET-1 and...

(Date:11/25/2009)...ewswire/ -- Regado Biosciences, a privately held c...ptamers with active control agents, announced that...enting at the Piper Jaffray 21st Annual Health Car...ork City. Dr. Mazzo,s presentation will be given ...clude an overview of the Company,s pipeline with e...

[0] Pharmasset Reports Fiscal Year End 2009 Financial Results [0] U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)[0] Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009